Chromium51EDTAChecker

Chromium-51 EDTA

radiopharmaceuticals QC URS & FS input.csv output.json radiochemical purity radionuclidic purity SPECT
Open selection

Utility description: Chromium-51 EDTA

Chromium-51 EDTA Quality Checker — Chromium-51 EDTA for GFR assessment

ℹ️  Utility checks critical parameters of chromium-51 EDTA:
    • Radiochemical purity (≥95%) — fraction of Cr-51 bound to EDTA
    • Free chromium-51 (≤5%) — unreacted chromium, accumulates in liver/spleen
    • pH (4.0–7.0) — critical for complex stability and safety
    • Sterility and apyrogenicity (endotoxins ≤175 EU/vial)
    • Appearance (clarity, absence of particles)
    • Stability control considering Cr-51 half-life (27.7 days)

⚠️  CRITICAL: 
    • Free chromium-51 >5% → accumulation in liver and spleen, distorted GFR results!
    • Radiochemical purity <95% → unreliable kidney function assessment!
    • Preparation age >48 hours → risk of complex degradation!

Usage:
  Chromium51EDTAChecker.exe                            → demo mode (console output)
  Chromium51EDTAChecker.exe input.csv output.json      → evaluate your data

Input format:
BatchNumber,ActivityMBqPerML,RadiochemicalPurityPercent,FreeChromiumPercent,pH,EndotoxinsEU,SterilityTest,Appearance,PreparationDate

Example (sterility: 0=sterile, 1=contaminated; appearance: 0=clear, 1=turbid):
  CR51-EDTA-2026-001,50.0,98.5,1.2,6.5,10.0,0,0,2026-05-20

Supported product types:
• Standard — standard solution for injection
• Kit — kit for ex tempore preparation

— WHY IS THIS NEEDED?
Chromium-51 EDTA is the "gold standard" for measuring GFR (glomerular filtration rate):
• 27.7-day half-life — convenient for logistics and multi-day studies
• Gamma emission (320 keV) — optimal for gamma camera detection
• Cr-51-EDTA complex is not metabolized, freely filtered in kidney glomeruli, and not secreted by tubules
• Used in suspected renal failure, before nephrotoxic chemotherapy, for dosing renally-excreted drugs

⚠️  CRITICAL:
• Radiochemical purity ≥95% — ensures that filtration of the complex, not free chromium, is measured
• Free chromium ≤5% — free Cr-51 binds to plasma proteins and accumulates in the reticuloendothelial system (liver, spleen), leading to underestimation of calculated GFR
• pH 4.0–7.0 — outside this range, the complex may degrade or cause phlebitis
• Sterility and endotoxins — mandatory for intravenous administration
• Appearance — solution must be clear, particle-free
• Stability — preparation is usable within 24–48 hours after preparation when stored refrigerated (2–8°C)

Key features:
• Radiochemical purity check (main quality parameter)
• Free chromium-51 control (critical impurity)
• Stability assessment based on preparation date (considering T½=27.7 days)
• Activity correction factor calculation for time of administration
• Physicochemical parameter checks (pH, sterility, endotoxins, appearance)

Critical parameters:
• Radiochemical purity: ≥95.0%
• Free chromium-51: ≤5.0%
• pH: 4.0–7.0
• Endotoxins: ≤175 EU/vial (or ≤5 EU/kg body weight)
• Sterility: no microbial growth
• Appearance: clear colorless solution
• Stability: ≤48 hours after preparation

💡 Usage tips:
1. Radiochemical purity controlled by thin-layer chromatography (TLC) or HPLC
2. For TLC use: Whatman No.1 paper, eluent — acetone/water (9:1). Rf Cr-51-EDTA ≈ 0.0, Rf free Cr-51 ≈ 0.8–1.0
3. Preparation is stable for 24–48 hours after preparation when stored refrigerated (2–8°C)
4. Activity is corrected to time of administration considering 27.7-day half-life
5. If free chromium >5% detected — batch rejected (GFR results will be inaccurate)!
6. Turbidity or presence of particles — absolute contraindication for administration!

⚠️ Note: Chromium-51 EDTA is the reference method for GFR measurement. Any deviation in radiochemical purity directly affects the accuracy of kidney function diagnosis. Free chromium creates background activity in the liver and spleen, interfering with correct clearance calculation.

input.csv

BatchNumber,ActivityMBqPerML,RadiochemicalPurityPercent,FreeChromiumPercent,pH,EndotoxinsEU,SterilityTest,Appearance,PreparationDate
CR51-EDTA-2026-001,50.0,98.5,1.2,6.5,10.0,0,0,2026-05-20
CR51-EDTA-2026-002,45.0,96.0,3.5,6.8,15.0,0,0,2026-05-22
CR51-EDTA-2026-003,55.0,94.0,6.5,6.2,8.0,0,0,2026-05-18

URS & FS — User Requirements and Functional Specification

This document describes the controlled interface and behaviour of Chromium51EDTAChecker for Chromium-51 EDTA.

Domain limits and critical parameters

Key fragments from the source description are shown below. Before production use, limits must be verified against the approved specification, registration dossier and local SOPs.
  • ℹ️ Utility checks critical parameters of chromium-51 EDTA:
  • • Radiochemical purity (≥95%) — fraction of Cr-51 bound to EDTA
  • • Free chromium-51 (≤5%) — unreacted chromium, accumulates in liver/spleen
  • • pH (4.0–7.0) — critical for complex stability and safety
  • • Sterility and apyrogenicity (endotoxins ≤175 EU/vial)
  • ⚠️ CRITICAL:
  • • Free chromium-51 >5% → accumulation in liver and spleen, distorted GFR results!
  • • Radiochemical purity <95% → unreliable kidney function assessment!
  • BatchNumber,ActivityMBqPerML,RadiochemicalPurityPercent,FreeChromiumPercent,pH,EndotoxinsEU,SterilityTest,Appearance,PreparationDate
  • Example (sterility: 0=sterile, 1=contaminated; appearance: 0=clear, 1=turbid):
  • • Cr-51-EDTA complex is not metabolized, freely filtered in kidney glomeruli, and not secreted by tubules
  • • Radiochemical purity ≥95% — ensures that filtration of the complex, not free chromium, is measured
  • • Free chromium ≤5% — free Cr-51 binds to plasma proteins and accumulates in the reticuloendothelial system (liver, spleen), leading to underestimation of calculated GFR
  • • Sterility and endotoxins — mandatory for intravenous administration

URS — User Requirements Specification

IDRequirementCriticalityAcceptance criterion
URS-001The utility shall accept an input.csv file with the exact headers defined in the data contract.HighThe file is processed without manual header editing.
URS-002The utility shall perform deterministic QC evaluation for Chromium-51 EDTA using input values, approved limits and domain rules.HighEach input row receives a PASS / WARNING / FAIL status.
URS-003The utility shall validate mandatory fields, data types, numeric ranges, units and pharmaceutical/radiochemical plausibility.HighSchema and conversion errors are explicitly reported.
URS-004The utility shall identify critical deviations related to radionuclidic purity, radiochemical purity, free radionuclide, impurities, pH, endotoxins and sterility when such fields are present.HighA critical deviation causes FAIL or a separate critical finding.
URS-005The utility shall generate output.json with machine-readable results, source values, warnings and failures.HighJSON is suitable for LIMS/ELN/MES integration and QA/QC review.
URS-006The utility shall not use machine learning to decide conformance.MediumThe result is based on explicit rules, thresholds and input values.
URS-007The utility shall preserve traceability between batch number, input values, applied rules and final status.HighThe output contains the batch identifier and the list of checked parameters.
URS-008The documentation shall support IQ/OQ preparation and inspection discussion with FDA/EMA/Roszdravnadzor or local regulators.MediumURS & FS, input.csv/output.json contract and test scenarios are supplied with the utility.

input.csv contract

#FieldTypeSamplePurpose
1BatchNumberstringCR51-EDTA-2026-001Batch or lot identifier used for traceability.
2ActivityMBqPerMLdecimal50.0Radioactivity value used for release, decay or dose-related assessment.
3RadiochemicalPurityPercentstring98.5Radiochemical purity; confirms the labelled chemical form and binding quality.
4FreeChromiumPercentdecimal1.2Free radionuclide / unbound species; important for non-target uptake and toxicity.
5pHdecimal6.5Solution pH; relevant for stability, compatibility and administration.
6EndotoxinsEUdecimal10.0Bacterial endotoxins; critical for parenteral administration.
7SterilityTestflag / boolean0Sterility result; critical release parameter.
8Appearancestring0Visual appearance / clarity parameter.
9PreparationDatedatetime / string2026-05-20Controlled input parameter used by the deterministic QC rules.
BatchNumber,ActivityMBqPerML,RadiochemicalPurityPercent,FreeChromiumPercent,pH,EndotoxinsEU,SterilityTest,Appearance,PreparationDate
CR51-EDTA-2026-001,50.0,98.5,1.2,6.5,10.0,0,0,2026-05-20
CR51-EDTA-2026-002,45.0,96.0,3.5,6.8,15.0,0,0,2026-05-22
CR51-EDTA-2026-003,55.0,94.0,6.5,6.2,8.0,0,0,2026-05-18

FS — Functional Specification

IDFunctionImplementation
FS-001CSV importRead input.csv in UTF-8/CSV-compatible format and validate the header and expected columns.
FS-002Schema validationCheck mandatory fields and column count; report unknown or missing key fields.
FS-003Type conversionConvert numeric, flag and text values; invalid formats are recorded as row-level errors.
FS-004Domain rule engineApply domain rules for Chromium-51 EDTA, including critical limits from the utility description and approved specification.
FS-005Status aggregationProduce final status: FAIL for critical failure, WARNING for non-critical deviation, PASS for conformance.
FS-006JSON exportWrite output.json with detailed checks, source values, warnings, failures and critical findings.
FS-007Audit supportKeep the result structure suitable for review, deviation investigation, calculation reproduction and IQ/OQ preparation.
FS-008Integration contractSupport the production scenario: LIMS/ELN/MES creates input.csv, the utility returns output.json, the portal displays description and documentation.

Example output.json

{
  "utilityId": "chromium51-edta-checker",
  "api": "Chromium-51 EDTA",
  "overallStatus": "PASS|WARNING|FAIL",
  "sourceFile": "input.csv",
  "checks": [
    {
      "parameter": "BatchNumber",
      "value": "CR51-EDTA-2026-001",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "ActivityMBqPerML",
      "value": "50.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "RadiochemicalPurityPercent",
      "value": "98.5",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "FreeChromiumPercent",
      "value": "1.2",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "pH",
      "value": "6.5",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "EndotoxinsEU",
      "value": "10.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "SterilityTest",
      "value": "0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Appearance",
      "value": "0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    }
  ],
  "criticalFindings": []
}

OQ/PQ test scenarios

IDScenarioExpected result
OQ-001Valid sample rowPASS or acceptable WARNING according to the rules.
OQ-002Mandatory column missingSchema error or FAIL.
OQ-003Non-numeric value in numeric fieldType-conversion error.
OQ-004Critical parameter outside limitFAIL and critical finding.
PQ-001User real batch/lotReviewed result with input.csv and output.json retained.

QA/QC and change control

  • Do not rename columns without updating the validator and test set.
  • Retain input.csv, output.json, executable version and checksum.
  • Before production use, perform IQ/OQ/PQ or equivalent CSV/CSA verification.
  • Critical radiopharmaceutical limits must be verified against the approved specification and local SOPs.

Included in packages

PetRad3: expanded PET/SPECT and radiopharmaceutical QC package

A curated suite for PET/SPECT radiopharmaceuticals, generator and cyclotron radionuclides, labelled compounds, radiochemical purity, breakthrough, sterility and endotoxin control.

Open

Radiology QC Suite

QC package for radiology and diagnostic imaging: radiopharmaceuticals, PET/SPECT, contrast media, iodinated and gadolinium products, plus particle, sterility and endotoxin checks.

Open

RPH isotope family: labelled cells and blood

In-111 and Cr-51 for labelled cells, blood volume, RBC/WBC and survival workflows.

Open

RPH organ/system: blood, cells and marrow

WBC/RBC/platelet labelling, blood volume, survival, blood-pool and cellular release workflows.

Open

RPH organ/system: hepatobiliary and GI

HIDA, mebrofenin, gallbladder, gastric emptying, GI transit, bleeding and liver/spleen imaging.

Open

RPH organ/system: renal and urinary

Renography, GFR/ERPF, renal uptake, DMSA/MAG3/DTPA and bladder-related workflows.

Open

RPH use case: labelled cells and blood-pool workflows

Leukocytes, red blood cells, platelets and autologous cell workflows: labeling efficiency, viability, free activity, recovery and release before reinjection.

Open

RPH workflow: generators and isotope purity

Generator eluate, breakthrough, radionuclidic purity, isotope mix and starting radionuclides.

Open

RPH workflow: imaging QC and quantitative interpretation

Acquisition, uptake, clearance, perfusion, transit, ejection fraction, segmentation and quantitative imaging.

Open

RPH workflow: instruments, devices and radiation safety

PET/gamma-camera state, calibration, detector QC, energy window, TOF, shielding and radiation safety.

Open

RPH workflow: product release QC

Assay, purity, sterility, endotoxins, pH, impurities, appearance and batch-release checks.

Open

RPH workflow: stability, storage, decay and waste

Kinetic stability, shelf life, decay correction, expiry, storage, trend and radioactive waste.

Open

RPH: combined radiopharmaceutical QC package

RPH combines PetRad, PetRad2 and PetRad3 into one umbrella package for PET/SPECT, therapeutic radionuclides, generators, labelled compounds, decay calculations, sterility, endotoxins and radiochemical/radionuclidic purity.

Open